secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ovid Therapeutics Inc. (OVID)
CIK:        0001636651
Form:       8-K
Filed at:   2023-12-06T23:59:59+00:00
Accession:  0000950170-23-068591
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Ovid Therapeutics CEO gifts 1.15M shares to family trusts for estate planning
-----------------------------------------------------------------------------

- CEO Jeremy Levin gifted 1,146,500 shares of Ovid common stock to family trusts for his two daughters.
- After gift, Dr. Levin holds 3,598,467 shares of outstanding common stock.
- Transfers made for no consideration as part of year-end estate tax planning.
- Form 4 filed with SEC on December 6, 2023 reporting the gifts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636651/000095017023068591/0000950170-23-068591-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636651/000095017023068591/ovid-20231204.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-068591

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer